Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nicholas Keen Insider Profile
4 Followers
Nicholas Keen, CSO at Bicycle Therapeutics, holds 69.80K shares in Bicycle Therapeutics (Ticker: BCYC). Most recently, Nicholas Keen Sold $790 shares of Bicycle Therapeutics on Apr 05, 2024 for an estimated value of 18.81K.
Profitable Transactions
2 out of 7 Profitable Transactions
Average Return
-10.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
CSO
Roles that Nicholas Keen holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 05, 2023 - Jan 05, 2024
Return:+45.20%
The most profitable trade made by Nicholas Keen
Nicholas Keen's Trading History
List of latest transactions for each holding click on a transaction to see Nicholas Keen's performance on stock
You May Also Like
Nicholas Keen insider profile FAQ
What is the percentage of profitable transactions made by Nicholas Keen?
The percentage of profitable transactions made by Nicholas Keen is 29%.
What is the average return per transaction made by Nicholas Keen?
The average return per transaction made by Nicholas Keen is -10.10%.
What stocks does Nicholas Keen hold?
Nicholas Keen holds: BCYC stocks.
What was Nicholas Keen’s latest transaction?
Nicholas Keen latest transaction was an Informative Sell of $18.81K.
What was Nicholas Keen's most profitable transaction?
Nicholas Keen’s most profitable transaction was an Informative Sell of BCYC stock on January 5, 2023. The return on the trade was 45.20%.
What is Nicholas Keen's role in Bicycle Therapeutics?
Nicholas Keen's role in Bicycle Therapeutics is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.